SEATTLE, July 22, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global genital warts treatment market is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to ...

BRISTOL, Tenn. — The Food and Drug Administration has approved a topical treatment for genital warts made by Graceway Pharmaceuticals, the drug maker said Monday. The FDA approved Zyclara (imiquimod) ...

BRISTOL, Tenn.--(BUSINESS WIRE)-- Graceway® Pharmaceuticals announced today that the Food and Drug Administration (FDA) has approved Zyclara® Cream for the treatment of external genital and perianal ...

Genital warts are a sexually transmitted disease that is caused by the human papillomavirus (HPV). There are various treatment and preventative options available for genital warts. External genital ...

Background There has been a rapid decline in the number of young heterosexuals diagnosed with genital warts at outpatient sexual health services since the national human papillomavirus (HPV) ...

Wartrol provides homeopathic treatment for genital warts. It is a specially formulated homeopathic blend of 5 key active ingredients, and each of the ingredients in it has been proven to treat genital ...

HPV is an extremely common STI responsible for around 50% of high-grade cervical precancers worldwide. HPV spreads through anal, vaginal, and oral sex and other skin-to-skin contact. The best ...

(MENAFNEditorial) March 13, 2018 Dr. Siavash Arani, M.D is a renown medical doctor and publisher who has written the book Condyloma Acuminatum, Cutting the Epidemic. His book discusses successful ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Genital Warts Treatment Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%.The ...

Between 2000 and 2011, a total of 6,014 women aged 15–44 years underwent in-patient treatment for vulval/vaginal warts. In 15–24 year old women in the pre-vaccine period the number of treatments did ...